{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T15:50:58Z","timestamp":1740153058920,"version":"3.37.3"},"reference-count":11,"publisher":"The Journal of Rheumatology","issue":"Suppl 2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:p>Given the impact of the coronavirus disease 2019 (COVID-19) on patients with psoriatic disease (PsD), a session was devoted at the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2022 annual meeting to discussing the current understanding of the risk of severe COVID-19 in patients with PsD. The effects of PsD and its treatment on prevention and treatment of COVID-19 with vaccinations, antiviral drugs, and monoclonal antibodies were discussed. The session concluded with a presentation on the perspectives of patient research partners about their experiences with COVID-19.<\/jats:p>","DOI":"10.3899\/jrheum.2023-0521","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T12:20:41Z","timestamp":1690892441000},"page":"27-30","source":"Crossref","is-referenced-by-count":0,"title":["Impact of COVID-19 on Patients With Psoriasis or Psoriatic Arthritis"],"prefix":"10.3899","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6620-0457","authenticated-orcid":false,"given":"Philip J.","family":"Mease","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2571-788X","authenticated-orcid":false,"given":"Peter","family":"Nash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9971-4115","authenticated-orcid":false,"given":"Suzanne","family":"Grieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8297-0275","authenticated-orcid":false,"given":"Vinod","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2262","published-online":{"date-parts":[[2023,8,1]]},"reference":[{"key":"2023110105251432000_50.Suppl_2.27.1","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s13671-022-00368-3","article-title":"Outpatient management of COVID-19: A primer for the Dermatologist","volume":"11","author":"Wang","year":"2022","journal-title":"Curr Dermatol Rep"},{"key":"2023110105251432000_50.Suppl_2.27.2","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2118542"},{"key":"2023110105251432000_50.Suppl_2.27.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02657-X"},{"key":"2023110105251432000_50.Suppl_2.27.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA2116044\/SUPPL_FILE\/NEJMOA2116044_DATA-SHARING.PDF"},{"key":"2023110105251432000_50.Suppl_2.27.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2116846"},{"key":"2023110105251432000_50.Suppl_2.27.6","doi-asserted-by":"crossref","first-page":"e458","DOI":"10.1016\/S2665-9913(22)00099-6","article-title":"Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases","volume":"4","author":"Goulenok","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"2023110105251432000_50.Suppl_2.27.7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.2832"},{"key":"2023110105251432000_50.Suppl_2.27.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102927"},{"key":"2023110105251432000_50.Suppl_2.27.9","doi-asserted-by":"crossref","first-page":"e159721","DOI":"10.1172\/jci.insight.159721","article-title":"Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune-mediated inflammatory diseases","volume":"7","author":"Dayam","year":"2022","journal-title":"JCI Insight"},{"key":"2023110105251432000_50.Suppl_2.27.10","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002622"},{"key":"2023110105251432000_50.Suppl_2.27.11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/1203475420977477","article-title":"Risk of depression in patients with psoriatic disease: a systematic review and meta-analysis","volume":"25","author":"Lukmanji","year":"2021","journal-title":"J Cutan Med Surg"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.2023-0521","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T12:31:18Z","timestamp":1698841878000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.2023-0521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":11,"journal-issue":{"issue":"Suppl 2","published-online":{"date-parts":[[2023,11,1]]},"published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.3899\/jrheum.2023-0521"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.2023-0521","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"type":"print","value":"0315-162X"},{"type":"electronic","value":"1499-2752"}],"subject":[],"published":{"date-parts":[[2023,8,1]]}}}